![Deepa Rajagopalan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Deepa Rajagopalan worked as the Vice President of New Products at Intercept Pharmaceuticals, Inc. She then served as the Chief Product & Strategy Officer at Viridian Therapeutics, Inc. Her former job at Intercept Pharmaceuticals, Inc. was followed by her role at Viridian Therapeutics, Inc. Dr. Rajagopalan obtained a doctorate degree from the University of Delhi.
She also holds an MBA from the London Business School.
Anciens postes connus de Deepa Rajagopalan
| Sociétés | Poste | Fin |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2023 |
| INTERCEPT PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Deepa Rajagopalan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
7
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
University of Delhi
 University of Delhi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London Business School
 London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viridian Therapeutics, Inc.
 Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
